The skin papers
The copper behind the glow peptide skin claim
Collagen is a firmer starting point than radiance. Even then, the formulation in the paper matters.
A cream result has a particular address
The glow peptide for skin argument begins with GHK-Cu. The skin-regeneration review describes GHK in human fluids and its decline with age, then connects the copper complex with collagen and other structural material around cells. Reviewed topical formulations were associated with improvements in firmness, elasticity and fine lines.
Skin strength and elasticity give me something firmer to think about than radiance. Collagen gives skin much of its tensile strength; elastin helps it spring back. Those are things a study can examine. A brighter complexion is a looser description; evidence for that outcome in the injected GLOW blend is lacking.
The tissue-remodeling review ranges across skin, animal and laboratory findings. Its breadth makes the ingredient interesting, but a cream and a multi-peptide injection reach different places in different ways. I do not grant the injection a cream's results just because the ingredient name recurs.
Loose skin is a claim about the blend, too
GHK-Cu reviews describe improved skin density, firmness and elasticity in topical work. That gives the sagging-skin claim a source, but the broader assessment of unapproved peptides supplies no controlled GLOW trial for loose skin. The preparation that was actually tested matters more than the adjective.
There is another reason to temper the enthusiasm: the skin review and the tissue-remodeling review share Pickart as an author. I value an author connecting a body of work, while treating a later synthesis as something different from a fresh replication. A thicker pile of reviews need not mean more separate confirmations.
The hair paper contains another ingredient
The closest controlled hair signal here is a 6-month trial in 45 men with androgenetic alopecia. It tested a topical complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide and found a significant increase in hair count compared with placebo. The formulation was neither pure GHK-Cu nor GLOW.
Hair counts are more concrete than a flattering photograph. Still, I cannot assign the result to the copper blend: the tested preparation had a different composition, and it went on the scalp. The extra ingredient helps define the tested preparation and deserves to stay visible.
GHK-Cu gene-expression research
The gene-data review discusses expression changes in cell work and database analysis. Gene expression means how actively a gene is being used. The review itself is a reason to resist the sweeping gene-count claims attached to this ingredient; the widely quoted count is an extrapolation.
Give me a defined, reproducible change over the largest gene count. Changes in a cell's activity do not establish a visible anti-aging effect in a person, let alone an effect of the full blend.
For glow peptide reviews, the 2026 clinical overview is the useful counterweight to the skin enthusiasm. It names GHK-Cu, BPC-157 and TB-500, acknowledges encouraging animal findings and leaves human safety unsettled. The reading list puts the older skin work beside that assessment.